Framework Agreement for the provision of a multigene test for patients with localised breast cancer, prognostic and predictive therapeutic assessment, Pathology Department, 2a+2pr
Official title
Original title: Acuerdo Marco prestación test multigénico pacientes cáncer de mama localizado valoración pronóstica y predictiva terapéutica s. anatomía patológica 2a+2pr
At a glance
- Instrument
- Tender
Classification CPV 33690000
Summary
A framework agreement for the provision of a multigene test to assess prognosis and predict therapeutic response in patients with localised breast cancer, for the Pathology Department. The term is stated as 2a+2pr in the notice.
This item is older than 14 days. Full details are in Pro.
Pro members get the full archive, eligibility & budget breakdowns, award data, weekly analyst brief and CSV/API export.
See pricingDates in this notice
- Published
- Deadline
Check the notice for the submission stage and exact time.
Organisations in this notice
Source & methodology
Source: Tenders Electronic Daily © European Union, reused under EU open data policy. Notice 482539-2026.
Structured automatically from the source notice; not yet reviewed by an analyst.